93
Participants
Start Date
March 31, 2005
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Carmustine
300 mg/m\^2 IV for 1 Day
Etoposide
Arm 1 = 200 mg/m\^2 IV Every 12 Hours x 4 Days; Arm 2 = 100 mg/m\^2 IV Every 12 Hours x 4 Days
Cytarabine
Arm 1 = 200 mg/m\^2 IV Every 12 Hours x 4 Days; Arm 2 = 100 mg/m\^2 IV Every 12 Hours x 4 Days
Melphalan
140 mg/m\^2 IV x 1 Day
Rituximab
Cohort 1, High-Dose Rituximab = 1000 mg/m\^2 IV On Days +1 and +8 After Stem Cell Infusion; Cohort 2, Standard Dose Rituximab = 375 mg/m\^2 IV On Days +1 and +8 After Stem Cell Infusion.
UT MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER